Research progress of traditional Chinese medicine against COVID-19 - 19/03/21
, Pan Liang a, b, 1 , Yue Ma a, b , Qin Sun a, b , Qingrong Pu a , Li Dong a , Gang Luo a , Maryam Mazhar a , Jiali Liu a, b , Raoqiong Wang a, ⁎ , Sijin Yang a, b, ⁎
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Graphical abstract |
Highlights |
• | Pathogenesis of SARS-CoV-2 infection is illustrated from both TCM and western medicine. |
• | High frequency herbs, active compounds, targets and signaling pathways are concluded from TCM prescriptions. |
• | We also summarize commonly used TCM characteristic therapies for the prevention and treatment of COVID-19. |
Abstract |
Background |
Currently, the number of confirmed cases and deaths of COVID-19 worldwide continues to rise, receiving great concern from the international community. However, there is no specific and widely accepted effective vaccines. The experience in controlling the outbreak in China has proven the effectiveness of traditional Chinese medicine (TCM).
Objectives |
This review aims to evaluate the role of TCM in COVID-19 treatment, hoping to provide references for prevention and control of global pandemic.
Data sources |
China National Knowledge Infrastructure, Web of Science, Baidu Scholar, ScienceDirect, Elsevier and PubMed were used to search literatures published from December 2019 to December 2020 by entering the keywords “Traditional Chinese medicine”, “COVID-19″, “Severe acute respiratory syndrome coronavirus 2″, “Pathogenesis”, “Syndrome differentiation”, “Prescriptions” and their combinations. Hence, we have performed an extensive review of research articles, reviews and primary scientific studies to identify TCM against COVID-19.
Results |
Among clinical treatments of COVID-19, several TCM prescriptions and characteristic therapies have been effectively suggested, the underlying mechanisms of which are mainly involved in antiviral, anti-inflammatory, immunomodulatory and organ-protective effects of multi-components acting on multi-targets at multi-pathways.
Conclusions |
This review may provide meaningful and feasible information that can be considered for the treatment of COVID-19 pandemic globally.
Le texte complet de cet article est disponible en PDF.Abbreviations : SARS-CoV, MERS-CoV, R0, ACE2, TMPRSS2, S protein, E protein, M protein, N protein, 3CLpro, PLpro, RdRp, IgM, IgG, ARDS, AKT1, AGTR1, CRP, CCL-2, CXCL-10, CASP3, DPP4, EGFR, ESR1, IL-1A, IL-1B, IL-1β, IL-1, IL-2, IL-6, IL-10, IP-10, IFN-γ, ICAM1, IFNG, MCP-1, MIP-1A, TNF-α, G-CSF, PTGS2, MAPK1, MAPK8, PI3K-Akt, HIF-1, MAPK3, NOS2, TLR4
Keywords : COVID-19, Traditional Chinese medicine, Prescriptions, Characteristic therapies, Underlying mechanism
Plan
Vol 137
Article 111310- mai 2021 Retour au numéro
Article précédent
- New insight and potential therapy for NAFLD: CYP2E1 and flavonoids
- Kaiyue Wang, Wangxiao Tan, Xiao Liu, Lina Deng, Lu Huang, Xiaoying Wang, Xiumei Gao
- The role of adiponectin in periodontitis: Current state and future prospects
- Zhaodan Wang, Zehao Chen, Fuchun Fang, Wei Qiu
Bienvenue sur EM-consulte, la référence des professionnels de santé.